A Philadelphia judge has urged the state Superior Court to affirm a $500,000 verdict awarded last year to a man who allegedly suffered excess growth of breast tissue as a result of taking the antipsychotic drug Risperdal.
The case presents the first chance for a state appeals court to address whether punitive damages claims should be allowed in the Risperdal trials.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
